Login

Journal Front Page

News & Events

  • Call for article for January 2025 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 December, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • October 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 4 (October 2024 Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

BIOANALYTICAL METHOD DEVELOPMENT AND ESTIMATION OF CEFOTAXIME USING RP-HPLC

Ankush Pushptode* Ankit Diwan, Kuldeep Ganju

Sagar Institute of Pharmacy and Technology, Bhopal (M.P), India

ABSTRACT

A Bioanalytical RP-HPLC assay method has been developed and validated for cefotaxime. An isocratic RP-HPLC method was developed with C18 column (250 mm ×4.6 mm i.d., 5 µm) utilizing a mobile phase of 20mM KH2P4 and acetonitrile (80:20 v/v) with UV detection at wavelength 260 nm at the flow rate 1.0ml/min. The proposed method was validated for sensitivity, selectivity, linearity, accuracy, precision, ruggedness, robustness and solution stability. The response of the drug was linear in the concentration range of 5-25µg/ml. Limit of detection and Limit of quantification was found to be 0.57µg/ml and 1.54µg/ml respectively. The % recovery ranged within 99.466±0.313 - 99.825±0.269%. Method, system, interday and intraday precision was found to be within the limits of acceptance criteria. Method was found to be rugged when analysis was carried out by different analyst. The method was suitable for the quality control of cefotaxime in injection formulations.

Keywords: Cefotaxime, Bioanalytical, Method development, Validation.


[Full Text Article]